These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4846402)

  • 1. [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
    Karev N; Blokhina N; Voznyi E; Perscin M
    Minerva Med; 1974 Jul; 65(52):2811-4. PubMed ID: 4846402
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with ftorafur treatment in breast cancer.
    Karev NI; Blokhina NG; Vozny EK; Pershin MP
    Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the effects of ftorafur and 5-fluorouracil in breast cancer (author's transl)].
    Karev NI; Blochina NG; Voznyj EK; Persin MP
    Cas Lek Cesk; 1975 Jul; 114(29):903-6. PubMed ID: 1098776
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with furanidyl-fluorouracil in advanced tumours of the breast.
    Cichy A; Jurga L; Klvana M
    Neoplasma; 1974; 21(6):723-32. PubMed ID: 4614094
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC; Falkson G; Tormey DC; Crowley J
    Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of Ftorafur (author's transl)].
    Rieche K; Matthes ML
    Arch Geschwulstforsch; 1975; 45(5):496-501. PubMed ID: 1212068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of toxicities induced by chemotherapy in breast cancer patients.
    Mehreen L; Khanam A
    Biomed Pharmacother; 2005 Oct; 59(9):524-7. PubMed ID: 16154313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The leucocyte nadir, a predictor of chemotherapy efficacy?
    Kvinnsland S
    Br J Cancer; 1999 Aug; 80(11):1681. PubMed ID: 10468282
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of ftorafur and hexamethylmelamine in advanced breast cancer].
    Lichinitser MR; Perevodchikova NI; Garin AM; Asserkritova IV; Vaarik GKh
    Vopr Onkol; 1978; 24(8):60-5. PubMed ID: 99870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 11. Results of treatment of malignant tumors with ftorafur.
    Blokhina NG; Vozny EK; Garin AM
    Cancer; 1972 Aug; 30(2):390-2. PubMed ID: 5051663
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
    Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
    Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of ftorafur for the treatment of 3d-4th stage].
    Plaude RK; Osman VI; Tabachnik BI; Purinia IZh; Gutman EKh
    Vopr Onkol; 1975; 21(3):44-7. PubMed ID: 1093324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical study of fluorouracil.
    Nadler SH; Moore GE
    Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modes of cytocidal action of antineoplastic agents and methods of their administration].
    Kimur K; Niitani H; Sakai Y; Chikada C; Shimoyama M
    Nihon Rinsho; 1975 May; 33(5):1862-72. PubMed ID: 1171280
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immediate results of the preoperative chemotherapy of breast cancer].
    Gol'dman VG
    Vopr Onkol; 1975; 21(10):19-22. PubMed ID: 810967
    [No Abstract]   [Full Text] [Related]  

  • 18. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
    Raida M; Schwabe W; Häusler P; Van Kuilenburg AB; Van Gennip AH; Behnke D; Höffken K
    Clin Cancer Res; 2001 Sep; 7(9):2832-9. PubMed ID: 11555601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.